<DOC>
	<DOCNO>NCT01953419</DOCNO>
	<brief_summary>This phase II trial aim assess efficacy safety pemetrexed patient pretreated metastatic gastric cancer .</brief_summary>
	<brief_title>Phase II Study Pemetrexed Advanced Recurrent Gastric Cancer After Chemotherapy</brief_title>
	<detailed_description>Patients enrol study receive pemetrexed 500mg/m2 , every 21 day , presence progressive disease unacceptable toxicity . All patient take dexamethasone 3.75 mg twice daily , start day continue day drug administration . Patients instructed take oral folic acid 400 mg daily begin 5 day first therapy final therapy.Patients receive Vitamin B12 3 cycle chemoherapy . Granulocyte colony-stimulating factor ( G-CSF ) , granulocyte-macrophage colony-stimulating factor ( GM-CSF ) Erythropoietin ( EPO ) allow , could use patient suffer bone marrow depression .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>1. histological confirm inoperable metastatic adenocarcinoma stomach gastroesophageal junction 2. age 18 80 year 3 . ECOG performance status 0 2 4. life expectancy ≥ 12 week 5. measurable disease Response Evaluation Criteria Solid Tumors ( RECIST ) 6. least one prior chemotherapy regimen 7. adequate bone marrow function define absolute neutrophil count equal 2000/mm3 8. platelet count equal 100,000/mm3 hemoglobin equal 8 g/dL 9. adequate renal function define creatinine le equal 1.25 × upper limit normal ( ULN ) creatinine clearance equal 60mL/min , 10. adequate liver function define bilirubin less equal 1.0×ULN aspartate transferase ( AST ) alanine transferase ( ALT ) less equal 2.5 ×ULN . 1. primary malignancy 2. symptomatic central nervous system metastasis 3. pregnancy lactation 4. cardiovascular event myocardial infarction previous 6 month congestive heart failure 5. ongoing infection 6. inability unwillingness interrupt nonsteroidal antiinflammatory drug 2 day pemetrexed administration unwillingness take folic acid vitamin B12 supplementation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>